The intrinsic relationship between the radiomics features and EGFR mutation status in patients with lung adenocarcinoma can be further explored through data mining to guide clinical decision-making, predict prognosis and evaluate efficacy (19, 22, 32). This evidence concerns the gene EGFR and lung adenocarcinoma.